23948sdkhjf

Dako appoints new CEO

The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.
Lars Holmkvist becomes new President and CEO of the Danish tissue-based cancer diagnostic company Dako. As of January 19 Lars Holmkvist took over from Patrik Dahlén.

Lars Holmkvist brings over 20 years‘ medical technology sales and management experience to Dako. His most recent position was President International of Applied Biosystems, preceded by various management positions with Medtronic, where he was instrumental in developing strategies and significantly boosting the company’s competitive position. He has also been marketing manager at EMEA’s Medical Division between 1991 och 1993.
Kommentera en artikel
Meddela redaktionen
Medlemsnytt
Se alla medlemsnyheter
Mest läst
Senaste nytt
Se senaste nytt
Utvalda artiklar
Utvalda nyheter från förstasidan
Fritt fram sprida desinformation om covid-19 på Twitter
Outsourcing som strategi för ökad trovärdighet
Roche lägger ner utveckling av Alzheimerbehandling
Viss effekt av Alzheimers-behandling bekräftas i studie – Bioarctic stiger på börsen
Astra Zeneca köper immunterapibolaget Neogene i miljardaffär
Svensk export av läkemedel ökar kraftigt
Andra Nordiska Medier
Rent
MedTech Magazine
Recycling

Sänd till en kollega

0.109